Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience-Reference-Cited by-同舟云学术

Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience

Published:2004-10 Issue:10 Volume:15 Page:1504-1509
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Rodriguez J.,Caballero M.D.,Gutierrez A.,Solano C.,Arranz R.,Lahuerta J.J.,Sierra J.,Gandarillas M.,Perez-Simon J.A.,Zuazu J.,Lopez-Guillermo A.,Sureda A.,Carreras E.,Garcia-Laraña J.,Marin J.,Garcia J.C.,Fernandez de Sevilla A.,Rifon J.,Varela R.,Jarque I.,Albo C.,Leon A.,SanMiguel J.,Conde E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/10/1504/406730/mdh391.pdf

Reference22 articles.

1. Treatment of non-Hodgkin's lymphoma;Armitage;N Engl J Med,1993

2. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma;Fisher;N Engl J Med,1993

3. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

4. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma;Philip;N Engl J Med,1987

5. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens—a Southwest Oncology Group trial;Stiff;J Clin Oncol,1998

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma;Cytotherapy;2024-05

2. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023;Journal of the National Comprehensive Cancer Network;2023-11

3. The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review;Biomolecules and Biomedicine;2023-03-30

4. Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review;Frontiers in Immunology;2023-01-17

5. Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in India;JCO Global Oncology;2022-05